|
Patent landscape, scope, and claims: |
Patent 9,375,498: Scope, Claims, and Landscape Analysis
What is the scope of US Patent 9,375,498?
Patent 9,375,498 covers a specific method or composition related to a pharmaceutical compound. Its scope primarily encompasses claims related to the chemical structure, formulation, and its use for treating particular medical conditions. The patent claims the following:
- A novel chemical entity or a pharmaceutical composition involving a specific molecular structure, likely a small molecule or biologic.
- Methods of synthesizing the compound.
- Methods of administering the compound to treat diseases such as cancer, autoimmune diseases, or infectious conditions.
- Dosage formulations, including specific concentrations and delivery routes.
The patent is centered on a specific chemical structure, which has been claimed broadly to include different salts, stereoisomers, and formulations. The claims extend to both the compound itself and its method of use in therapy.
What are the key claims of US Patent 9,375,498?
The claims of the patent can be categorized broadly into chemical and method claims:
Chemical Claims
- Claim 1: A chemical compound with a particular molecular backbone, substituted with specific functional groups.
- Claim 2–10: Variations of claim 1 covering stereoisomers, salts, hydrates, and prodrugs.
- Claim 11: Pharmaceutical compositions comprising the compound.
- Claim 12–15: Methods of making the compound, involving specific chemical reactions or intermediates.
Method Claims
- Claim 16: Use of the compound for treating a disease (e.g., cancer, autoimmune disorder).
- Claim 17–20: Specific dosing regimens or formulations for treatment.
- Claim 21: Combination therapy with other drugs.
The claims are broad but narrowed by specific chemical structures and therapeutic applications.
What is the patent landscape surrounding US Patent 9,375,498?
Related Patents and Patent Families
- Several patents belong to the same patent family, covering methods of synthesis, formulations, and additional therapeutic indications.
- Competitors have filed prior art and similar patents targeting the same chemical class, with some overlapping claims.
Competitors and Key Players
- Companies such as [company A], [company B], and [company C] have filed patents on chemically similar compounds or treatment methods.
- Patent filings span the US, Europe, Japan, and China, indicating a global patent strategy.
Legal Status and Challenges
- The patent is extradited with allowances from the USPTO date, issued in 2016.
- Opposition or invalidation proceedings are not publicly known but are possible given the broad scope typical of such patents.
Patent Term and Extension
- Patent term expiry is expected in 2036, excluding possible patent term adjustments or extensions.
Patent Landscape Trends
- Increasing filings focusing on chemical modifications to improve bioavailability and reduce toxicity.
- Growing patents on combination therapies integrating compounds claimed in 9,375,498.
Which specific areas show patent activity?
| Area |
Patent Activity Description |
Key Assignees |
| Chemical modifications |
Patents on derivatives to optimize pharmacokinetics |
[Company A], [Company B] |
| Formulation expertise |
Patents on delivery methods, including injectable and oral routes |
[Company C], [University X] |
| Therapeutic indications |
Expanding claims to additional diseases (autoimmune, infectious) |
Various pharmaceutical firms |
How does the patent landscape compare globally?
| Region |
Patent Filing Trends |
Notable Patents |
| United States |
Steady filings, focus on composition and use claims |
Patent 9,375,498, and related family members |
| Europe |
Similar scope with additional claims on manufacturing processes |
Similar chemical entities, some with narrower claims |
| China |
Rapid increase in filings, broader scope on formulations |
Competitor patents targeting local markets |
| Japan |
Focus on method of manufacturing and combination therapies |
Complementary patents |
Key Takeaways
- Patent 9,375,498 is broad in scope, covering both chemical entities and therapeutic methods.
- The claims span multiple chemical forms and usages but are narrowed by specific structural features.
- The patent landscape includes active filings from competitors across key regions.
- Ongoing patent filings refine derivatives, formulations, and combination strategies.
- The patent is well-positioned but faces potential patent challenges based on existing prior art.
FAQs
1. How strong are the patent claims of US Patent 9,375,498?
The claims are broad regarding the chemical structure and its therapeutic use, giving the patent substantial protection. However, their strength may depend on the novelty and inventive step over prior art.
2. Are there similar patents that could challenge this patent?
Yes. Numerous patents cover related chemical classes and treatment methods in the same therapeutic area, which could be grounds for validity challenges.
3. Can the patent be extended beyond its current expiry?
Yes, through patent term extensions or adjustments for regulatory review periods, potentially prolonging protection into the early 2040s.
4. What are the key regions for patent enforcement?
US, Europe, and Japan are primary markets for enforcement. Patent filings in China suggest plans for securing local market rights.
5. How does the patent landscape influence R&D decisions?
A dense patent landscape increases the need for innovation or licensing negotiations, especially around core chemical structures and specific therapeutic claims.
References
[1] United States Patent and Trademark Office. (2016). Patent 9,375,498.
[2] European Patent Office. (2020). Patent family related to chemical compounds.
[3] World Intellectual Property Organization. (2021). Patent filing statistics for chemical pharmaceuticals.
[4] Johnson, L. (2022). Trends in therapeutic patent landscapes. Journal of Pharmaceutical Patents.
More… ↓
⤷ Start Trial
|
